Catherine Schulte
Stock Analyst at Baird
(4.09)
# 525
Out of 4,970 analysts
139
Total ratings
58.12%
Success rate
10.33%
Average return
Main Sectors:
Stocks Rated by Catherine Schulte
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| A Agilent Technologies | Maintains: Outperform | $141 → $142 | $128.48 | +10.52% | 17 | Aug 28, 2025 | |
| MTD Mettler-Toledo International | Maintains: Neutral | $1,210 → $1,230 | $1,287.79 | -4.49% | 10 | Aug 4, 2025 | |
| AVTR Avantor | Maintains: Outperform | $18 → $15 | $13.19 | +13.72% | 13 | Aug 4, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Outperform | $553 → $567 | $489.49 | +15.83% | 28 | Jul 24, 2025 | |
| DHR Danaher | Maintains: Outperform | $226 → $229 | $199.03 | +15.06% | 11 | Jul 23, 2025 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Neutral | $3 → $2 | $2.37 | -15.43% | 6 | May 13, 2025 | |
| EXAS Exact Sciences | Maintains: Outperform | $69 → $72 | $51.41 | +40.05% | 14 | May 2, 2025 | |
| QGEN Qiagen | Maintains: Neutral | $42 → $43 | $47.04 | -8.59% | 4 | Apr 21, 2025 | |
| TECH Bio-Techne | Downgrades: Neutral | $88 → $68 | $52.92 | +28.50% | 11 | Feb 19, 2025 | |
| CSTL Castle Biosciences | Maintains: Outperform | $42 → $38 | $23.09 | +64.57% | 7 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $56 → $33 | $25.63 | +28.76% | 3 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $335 → $281 | $97.68 | +187.67% | 7 | Sep 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $208 → $217 | $299.69 | -27.59% | 7 | Oct 30, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $17 → $20 | $166.56 | -87.99% | 1 | Jun 28, 2018 |
Agilent Technologies
Aug 28, 2025
Maintains: Outperform
Price Target: $141 → $142
Current: $128.48
Upside: +10.52%
Mettler-Toledo International
Aug 4, 2025
Maintains: Neutral
Price Target: $1,210 → $1,230
Current: $1,287.79
Upside: -4.49%
Avantor
Aug 4, 2025
Maintains: Outperform
Price Target: $18 → $15
Current: $13.19
Upside: +13.72%
Thermo Fisher Scientific
Jul 24, 2025
Maintains: Outperform
Price Target: $553 → $567
Current: $489.49
Upside: +15.83%
Danaher
Jul 23, 2025
Maintains: Outperform
Price Target: $226 → $229
Current: $199.03
Upside: +15.06%
Maravai LifeSciences Holdings
May 13, 2025
Maintains: Neutral
Price Target: $3 → $2
Current: $2.37
Upside: -15.43%
Exact Sciences
May 2, 2025
Maintains: Outperform
Price Target: $69 → $72
Current: $51.41
Upside: +40.05%
Qiagen
Apr 21, 2025
Maintains: Neutral
Price Target: $42 → $43
Current: $47.04
Upside: -8.59%
Bio-Techne
Feb 19, 2025
Downgrades: Neutral
Price Target: $88 → $68
Current: $52.92
Upside: +28.50%
Castle Biosciences
Mar 1, 2023
Maintains: Outperform
Price Target: $42 → $38
Current: $23.09
Upside: +64.57%
Nov 21, 2022
Maintains: Outperform
Price Target: $56 → $33
Current: $25.63
Upside: +28.76%
Sep 22, 2020
Maintains: Neutral
Price Target: $335 → $281
Current: $97.68
Upside: +187.67%
Oct 30, 2019
Maintains: Neutral
Price Target: $208 → $217
Current: $299.69
Upside: -27.59%
Jun 28, 2018
Maintains: Outperform
Price Target: $17 → $20
Current: $166.56
Upside: -87.99%